Procter & Gamble CoPG:NYQ

84.04
0.17 / 0.20%
5.22m
4.84%
0.3916
Real-time price in USDToday's changeShares traded1 year changeBeta
As of Sep 16 2014 20:28 BST.

Consensus recommendation

As of Sep 12, 2014, the consensus forecast amongst 30 polled investment analysts covering The Procter & Gamble Company advises that the company will outperform the market. This has been the consensus forecast since the sentiment of investment analysts improved on May 20, 2009. The previous consensus forecast advised investors to hold their position in The Procter & Gamble Company.

Previous recommendations
Last year3 months ago2 months ago4 weeks agoLatest
Mouseover chart recommendation details.
Latest recommendation
Buy9
Outperform6
Hold13
Underperform1
Sell0
No opinion0

Share price forecast

The 16 analysts offering 12 month price targets for The Procter & Gamble Company have a median target of 87.50, with a high estimate of 97.00 and a low estimate of 80.00. The median estimate represents a 5.09% increase from the last price of 83.26. View Full Financials

High+15.3 %97.00
Med+4.0 %87.50
Low-4.9 %80.00

Dividends

In 2014, Procter & Gamble Co reported a dividend of 2.45 USD, which represents a 7.02% increase over last year. The 17 analysts covering the company expect dividends of 2.61 USD for the upcoming fiscal year, an increase of 6.57%. View Full Financials

Div growth (TTM)+7.02%
  • Mouseover chart for details.
  • Dividend forecast
  • Quarter 1
  • Quarter 2
  • Quarter 3
  • Quarter 4

Earnings history & estimates

On Aug 01, 2014, The Procter & Gamble Company reported 4th quarter 2014 earnings of 0.95 per share. This result was in line with the consensus of the 23 analysts following the company and exceeded last year's 4th quarter results by 20.25%.
The next earnings announcement is expected on Oct 24, 2014. View Full Interim Financials

Average growth rate+6.36%

The Procter & Gamble Company reported annual 2014 earnings of 4.22 per share on Aug 01, 2014. View Full Annual Financials

Average growth rate+0.74%
  • Mouseover chart for details.
  • Reported results
  • Forecasts
  • Pos/Neg restatement

Revenue

The Procter & Gamble Company had 4th quarter 2014 revenues of 20.157bn. This missed the 20.479bn consensus estimate of the 20 analysts following the company. This was 1.96% below the prior year's 4th quarter results. View Full Interim Financials

Average growth rate-0.49%

The Procter & Gamble Company had revenues for the full year 2014 of 83.062bn. This was 1.31% below the prior year's results. View Full Annual Financials

Average growth rate+1.30%
  • Mouseover chart for details.
  • Reported results
  • Forecasts
  • Pos/Neg restatement
© Thomson Reuters Click for restrictions.

Real-time data provided by BATS.

All markets data located on FT.com is subject to the FT Terms & Conditions.

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.